xabarchixabarchiABARCHI
Economics

Ozempic-maker sues rival, accusing it of false advertising

Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.

Novo Nordisk, the pharmaceutical company behind Wegovy and Ozempic, has initiated legal proceedings against its main competitor, Eli Lilly, alleging false advertising. The lawsuit claims Eli Lilly has suggested

pharmaceutical lawsuitfalse advertisingweight-loss drugsnovo nordiskeli lillydrug competitionmounjaroozempic

Cookies on xabarchi

We use cookies to remember your language and theme, and to count how many people are reading right now — that count is anonymous, lasts only while your browser is open, and cannot be tied to you or to another visit. With your permission we also measure how the site is read: Microsoft Clarity, which records page views and on-page interactions, and our own count of returning readers. Nothing that recognises you across visits is measured until you accept.